Endoscopic Devices - New Zealand | Statista Market Forecast

Revenue in the Endoscopic Devices market market in New Zealand is projected to reach US$73.73m in 2024.
Revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 7.49%, which will result in a market volume of US$105.80m by 2029.
In a global context, the majority of revenue will be generated the United States, where it is expected to reach US$10.39bn in 2024.
In New Zealand, the demand for advanced endoscopic devices is rapidly increasing, driven by a growing emphasis on minimally invasive surgical techniques and improved patient outcomes.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in New Zealand is experiencing mild growth, influenced by factors such as advancements in minimally invasive procedures, increasing healthcare expenditure, and the rising demand for early diagnosis and treatment options among patients.

Customer preferences: Consumers in New Zealand are increasingly prioritizing health and wellness, leading to a growing preference for endoscopic devices that offer minimally invasive treatment options. This trend is driven by an aging population seeking efficient solutions for early diagnosis and treatment, alongside a cultural emphasis on proactive healthcare. Additionally, younger demographics are more inclined to explore advanced medical technologies, spurred by greater health awareness and the desire for quicker recovery times, thus influencing market demand for innovative endoscopic solutions.

Trends in the market: In New Zealand, the Endoscopic Devices Market is experiencing a notable shift toward advanced minimally invasive technologies, driven by an increasing consumer demand for efficient healthcare solutions. The aging population is seeking early diagnosis and treatment options, fostering a rise in innovative endoscopic procedures. Concurrently, younger individuals are embracing these technologies, motivated by heightened health awareness and the pursuit of quicker recovery times. This convergence is reshaping industry dynamics, emphasizing the need for stakeholders to invest in research and development to meet evolving patient expectations and improve clinical outcomes.

Local special circumstances: In New Zealand, the Endoscopic Devices Market is influenced by a combination of geographic isolation and a strong emphasis on healthcare quality. The country's remote location necessitates efficient healthcare delivery systems, prompting the adoption of advanced minimally invasive technologies that enhance patient access to specialized procedures. Culturally, there is a significant focus on holistic health and well-being, leading to increased patient engagement in treatment decisions. Regulatory frameworks also encourage innovation while ensuring patient safety, which shapes the competitive landscape and drives technological advancements in endoscopic procedures.

Underlying macroeconomic factors: The Endoscopic Devices Market in New Zealand is influenced by several macroeconomic factors, including national economic health, global supply chain dynamics, and fiscal policies. The country's robust healthcare funding, supported by government initiatives, facilitates investment in advanced medical technologies. Additionally, rising healthcare costs and an aging population drive demand for minimally invasive procedures, encouraging innovation in endoscopic devices. Global economic trends, such as shifts in manufacturing costs and trade policies, also impact the availability and pricing of these devices, ultimately shaping market performance and accessibility for healthcare providers and patients alike.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.